Trial · NCT01432522
A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine
NCT01432522, Not applicable, Completed, Siriraj Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine. Trials, record NCT01432522. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01432522
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study for Absorption of Intranasal Epinephrine Compared to Conventional Intramuscular Epinephrine
- NCT number
- NCT01432522
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 12 participants, estimated
- Lead sponsor
- Siriraj Hospital
- Conditions
- Anaphylaxis
- Interventions
- Epinephrine
- First posted
- 2011-09-13
- Last updated
- 2011-09-13
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Composite of Pharmacokinetics of epinephrine | predose, 5 , 10, 15, 20, 30, 45, 60, 90, 120, 180 minutes post-dose | Cmax, Area Under Curve, Tmax of epinephrine compare between 0.3 mg intramuscular and 5 mg intranasal route |
| Secondary | Numbers of participants with adverse events as a measure of safety and tolerability | 1 year | Any side effects from such administration such as bad smelling, sorethroat. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01432522
GET https://conductscience.org/api/trials/v1/NCT01432522/registered